Skip to main content

Kaleido Biosciences Inc Assigned Short-Term B2 & Long-Term B1 Credit Rating

For exceptional and strong liquidity assessments, we characterize standing in the credit markets as generally high, and for adequate liquidity, we view standing in the credit markets as satisfactory. We distinguish between these descriptors based on analytical judgment and mainly consider the diversity of funding sources available to an entity.Kaleido Biosciences Inc Assigned Short-Term B2 & Long-Term B1 Credit Rating. How Does Credit Rating Model Work?

Rating Model for Kaleido Biosciences Inc: We estimate the credit risk parameters by Volume and Stepwise Regression

Credit Ratings for Kaleido Biosciences Inc as of 06 Mar 2022


Credit Rating Short-Term Long-Term Senior
AI Rating Class*B2B1
Semantic Signals5583
Financial Signals9078
Risk Signals3651
Substantial Risks3036
Speculative Signals5131

*Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines.Take a look at: How Does Credit Rating Model Work?

Financial Analysis for Kaleido Biosciences Inc


Financials: PREMIUM
Income Statement: PREMIUM
Balance Sheet: PREMIUM
Cash Flow: PREMIUM
Valuation: PREMIUM
Inventory Valuation: PREMIUM
Dividends: PREMIUM
Operating Performance: PREMIUM
Sustainability: PREMIUM
Price vs. Fair Value: PREMIUM
Stock Analysis: PREMIUM

Analyst Rating for Kaleido Biosciences Inc


Is it the right time to buy or sell? : PREMIUM
Fair Value : PREMIUM
Trailing Returns : PREMIUM

Key Statistics for Kaleido Biosciences Inc


Price/Book : PREMIUM
Price/Cash Flow : PREMIUM
Price/Sales : PREMIUM
Price/Earnings : PREMIUM
Operating Income : PREMIUM
Net Income : PREMIUM
Quick Ratio : PREMIUM
Current Ratio : PREMIUM
Interest Coverage : PREMIUM
Debt/Equity : PREMIUM
Return on Assets : PREMIUM
Return on Equity : PREMIUM
Invested Capital : PREMIUM
Net Margin : PREMIUM
EBITDA Margin : PREMIUM
Days Sales Outstanding : PREMIUM
Payables Period : PREMIUM
Cash Conversion Cycle : PREMIUM
Recieveables Turnover : PREMIUM
Inventory Turnover : PREMIUM
Fixed Assets Turnover : PREMIUM
Asset Turnover : PREMIUM
Operating Cash Flow Growth : PREMIUM
Free Cash Flow Growth : PREMIUM
Free Cash Flow/Sales : PREMIUM
Free Cash Flow/Net Income : PREMIUM
Free Cash Flow/Share : PREMIUM

Credit Report for Kaleido Biosciences Inc


Risk Report : PREMIUM
Credit Report : PREMIUM
Commercial Credit Report : PREMIUM

Audit Reports & Filings for Kaleido Biosciences Inc


Audit Reports : PREMIUM
Principal Risk and Viability : PREMIUM
Risk Analysis : PREMIUM
Retail Technology Environment, Including IT Security : PREMIUM
SEC Filings : PREMIUM
Bankruptcy Filings : PREMIUM
Suit & Judgment Filings : PREMIUM
Tax Lien Filings : PREMIUM

Market Research for Kaleido Biosciences Inc


Customer Reviews : 8474 reviews PREMIUM
Interviews : PREMIUM
Focus Groups : PREMIUM
Market Share Analysis : PREMIUM


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |